Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle Grant Type Focus Area Country Application Due Date Real-World Data Generation with Elranatamab in Relapsed/Refractory Multiple MyelomaRelease Date:Research Oncology Spain Optimizing Clinical Care Delivery for Patients with Multiple Myeloma Receiving Bispecific AntibodiesRelease Date:Quality Improvement Oncology All Enhancing HCP Education in Maternal VaccinationRelease Date:Education Vaccines Saudi Arabia Diagnosis and Treatment of Cancer CachexiaRelease Date:Education Oncology All Evidence-Based Education on the Potential Impact of a Generic JAK Inhibitor on the Management of Rheumatologic DiseasesRelease Date:Education Inflammation & Immunology USA B-cell Maturation Antigen (BCMA) Bi-Specific Antibodies (BsAbs) in Relapsed/Refractory Multiple Myeloma (RRMM)Release Date:Education Oncology USA Education on Mechanism of Action of JAK3 and TEC Family Kinase Role in Alopecia AreataRelease Date:Education Inflammation & Immunology USA 2026 Hemophilia Fellowship – United StatesRelease Date:Fellowship Rare Disease All Pediatric Pneumococcal Disease and Serotype Distribution: Surveillance Studies in Saudi ArabiaRelease Date:Research Vaccines Saudi Arabia Optimising Ulcerative Colitis Care: Bridging Knowledge Gaps, Integrating Biomarker-Based Strategies, and Advancing EquityRelease Date:Education Inflammation & Immunology Australia Surveillance of Pneumococcal Disease Serotype Distribution in Pediatric and Adult Pneumococcal Disease in TürkiyeRelease Date:Research Vaccines Turkey Surveillance of Pneumococcal Disease Serotype Distribution in Pediatric and Adult Pneumococcal Disease in TürkiyeRelease Date:Research Vaccines Turkey Title Grant Type Focus Area Country Application Due Date Innovative digital educational channels in Oncology for health care professionals or patients to increase local awarenessRelease Date:Education Oncology Spain Individualized Menopause CareRelease Date:Education Internal Medicine USA Approaches to Improve Delivery of Quality of Care for Patients with Inflammatory, and Immune Skin DiseasesRelease Date:Quality Improvement Inflammation & Immunology Japan Promoting Appropriate Diagnosis and Treatment of Migraine CareRelease Date:Education Internal Medicine Japan Burden of RSV Disease - Analyzing Local Surveillance Data for Older Adults (EM Geographic Scope)Release Date:Research Inflammation & Immunology All Improving Education Disparities of Non-Specialized Health Care Providers to Deliver Appropriate Medical Care for IBD PatientsRelease Date:Education Inflammation & Immunology Argentina, Brazil, India, Russia, Saudi Arabia, Singapore, Turkey, United Arab Emirates Increasing Understanding of the Evolving Hemophilia Treatment LandscapeRelease Date:Education Rare Disease USA Non-Muscle Invasive Bladder Cancer Emerging Markets Needs AssessmentRelease Date:Education Oncology Argentina, Brazil, Colombia, Hong Kong, India, Mexico, Saudi Arabia, Taiwan, Turkey, United Arab Emirates Addressing Educational Barriers to Equitable Care for Patients with Immune Inflammatory DiseasesRelease Date:Education Inflammation & Immunology All Juvenile Idiopathic Arthritis (JIA) Patient EducationRelease Date:Education Inflammation & Immunology USA Updates on RSV in Older Adults for PharmacistsRelease Date:Education Vaccines USA PARP-inhibitor Combination Treatments in Prostate Cancer, a Global PerspectiveRelease Date:Education Oncology All